Delivery of EVs derived from endothelial progenitor cells can enhance human islet vascularization, promoting insulin secretion and islet survival [81], and it is hypothesized that EV delivery early in T1DM may help restore a patient’s original islet cells [153]. Here, INS is linked to type 1 diabetes mellitus.